MannKind and Senseonics Q2 ’19 Earnings Updates
MannKind and Senseonics hosted their Q2 ’19 earnings calls and provided updates to their respective diabetes businesses. Below, FENIX provides highlights and insights from the calls.
MannKind and Senseonics hosted their Q2 ’19 earnings calls and provided updates to their respective diabetes businesses. Below, FENIX provides highlights and insights from the calls.
MannKind announced it formed a partnership with GoodRx to “help raise awareness on ways patients can save money on their mealtime insulin.” Recall, GoodRx is a platform designed for patients without insurance or high-deductible plans to help them compare drug prices and identify savings opportunities (e.g. copay cards). Of note, the MannKind press release appears to suggest that the sole purpose of the partnership is to promote the Afrezza copay card. Below, FENIX provides brief thoughts on the MannKind partnership with GoodRx.